×
For best experience we recommend to activate Javascript in your browser.
DDO antibody (AA 270-369)
This anti-DDO antibody is a Mouse Polyclonal antibody detecting DDO in WB and ELISA. Suitable for Human. This Primary Antibody has been cited in 1 publication.
Quick Overview for DDO antibody (AA 270-369) (ABIN563670)
Target
See all DDO Antibodies
DDO
(D-Aspartate Oxidase (DDO))
Reactivity
All reactivities for DDO antibodies
Human
Host
All hosts for DDO antibodies
Mouse
Clonality
All clonalities for DDO antibodies
Polyclonal
Conjugate
All conjugates for DDO antibodies
This DDO antibody is un-conjugated
Application
All applications for DDO antibodies
Western Blotting (WB), ELISA
Product Details anti-DDO Antibody
(hide)
Binding Specificity
All epitopes for DDO antibodies
AA 270-369
Purpose
Mouse polyclonal antibody raised against a partial recombinant DDO.
Sequence
WNLSPDAENS REILSRCCAL EPSLHGACNI REKVGLRPYR PGVRLQTELL ARDGQRLPVV HHYGHGSGGI SVHWGTALEA ARLVSECVHA LRTPIPKSNL
Cross-Reactivity
Human
Characteristics
Antibody Reactive Against Recombinant Protein.
Immunogen
DDO (NP_003640, 270 a.a. ~ 369 a.a) partial recombinant protein with GST tag.
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
50 % glycerol
Handling Advice
Aliquot to avoid repeated freezing and thawing.
Storage
-20 °C
Storage Comment
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
References for anti-DDO antibody (ABIN563670)
(hide)
Huang, Lee, Blackshaw : "D-Aspartate and D-aspartate oxidase show selective and developmentally dynamic localization in mouse retina. " in: Experimental eye research , Vol. 86 , Issue 4 , pp. 704-9 , (2008 ) (PubMed ).
Target Details for DDO
(hide)
Target
DDO
(D-Aspartate Oxidase (DDO))
Alternative Name
DDO
Background
Full Gene Name: D-aspartate oxidase Synonyms: DASOX,DDO-1,DDO-2,FLJ45203
Gene ID
8528
NCBI Accession
NM_003649
Recently viewed
(hide)
Chat with us , powered by LiveChat